BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 25191940)

  • 1. Difluoro-dioxolo-benzoimidazol-benzamides as potent inhibitors of CK1δ and ε with nanomolar inhibitory activity on cancer cell proliferation.
    Richter J; Bischof J; Zaja M; Kohlhof H; Othersen O; Vitt D; Alscher V; Pospiech I; García-Reyes B; Berg S; Leban J; Knippschild U
    J Med Chem; 2014 Oct; 57(19):7933-46. PubMed ID: 25191940
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 2-Benzamido-N-(1H-benzo[d]imidazol-2-yl)thiazole-4-carboxamide derivatives as potent inhibitors of CK1δ/ε.
    Bischof J; Leban J; Zaja M; Grothey A; Radunsky B; Othersen O; Strobl S; Vitt D; Knippschild U
    Amino Acids; 2012 Oct; 43(4):1577-91. PubMed ID: 22331384
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery of Inhibitor of Wnt Production 2 (IWP-2) and Related Compounds As Selective ATP-Competitive Inhibitors of Casein Kinase 1 (CK1) δ/ε.
    García-Reyes B; Witt L; Jansen B; Karasu E; Gehring T; Leban J; Henne-Bruns D; Pichlo C; Brunstein E; Baumann U; Wesseler F; Rathmer B; Schade D; Peifer C; Knippschild U
    J Med Chem; 2018 May; 61(9):4087-4102. PubMed ID: 29630366
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimized 4,5-Diarylimidazoles as Potent/Selective Inhibitors of Protein Kinase CK1δ and Their Structural Relation to p38α MAPK.
    Halekotte J; Witt L; Ianes C; Krüger M; Bührmann M; Rauh D; Pichlo C; Brunstein E; Luxenburger A; Baumann U; Knippschild U; Bischof J; Peifer C
    Molecules; 2017 Mar; 22(4):. PubMed ID: 28338621
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IC261 suppresses progression of hepatocellular carcinoma in a casein kinase 1 δ/ε independent manner.
    Yuan F; Li D; Guo M; Fang T; Sun J; Qi F; Rao Q; Zhao Z; Huang P; Yang B; Xia J
    Biochem Biophys Res Commun; 2020 Mar; 523(3):809-815. PubMed ID: 31954519
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of altered expression and activity levels of CK1δ and ɛ on tumor growth and survival of colorectal cancer patients.
    Richter J; Ullah K; Xu P; Alscher V; Blatz A; Peifer C; Halekotte J; Leban J; Vitt D; Holzmann K; Bakulev V; Pinna LA; Henne-Bruns D; Hillenbrand A; Kornmann M; Leithäuser F; Bischof J; Knippschild U
    Int J Cancer; 2015 Jun; 136(12):2799-810. PubMed ID: 25404202
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IC261 induces cell cycle arrest and apoptosis of human cancer cells via CK1δ/ɛ and Wnt/β-catenin independent inhibition of mitotic spindle formation.
    Cheong JK; Nguyen TH; Wang H; Tan P; Voorhoeve PM; Lee SH; Virshup DM
    Oncogene; 2011 Jun; 30(22):2558-69. PubMed ID: 21258417
    [TBL] [Abstract][Full Text] [Related]  

  • 8. N-(1H-Pyrazol-3-yl)quinazolin-4-amines as a novel class of casein kinase 1δ/ε inhibitors: Synthesis, biological evaluation and molecular modeling studies.
    Karthikeyan C; Jharia P; Waiker DK; Nusbaum AC; Amawi H; Kirwen EM; Christman R; Arudra SKC; Meijer L; Tiwari AK; Trivedi P
    Bioorg Med Chem Lett; 2017 Jun; 27(12):2663-2667. PubMed ID: 28487075
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of dual casein kinase 1δ/1ε (CK1δ/ε) inhibitors for treatment of breast cancer.
    Monastyrskyi A; Nilchan N; Quereda V; Noguchi Y; Ruiz C; Grant W; Cameron M; Duckett D; Roush W
    Bioorg Med Chem; 2018 Feb; 26(3):590-602. PubMed ID: 29289448
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural basis for the interaction between casein kinase 1 delta and a potent and selective inhibitor.
    Long A; Zhao H; Huang X
    J Med Chem; 2012 Jan; 55(2):956-60. PubMed ID: 22168824
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Casein kinase 1 is a therapeutic target in chronic lymphocytic leukemia.
    Janovska P; Verner J; Kohoutek J; Bryjova L; Gregorova M; Dzimkova M; Skabrahova H; Radaszkiewicz T; Ovesna P; Vondalova Blanarova O; Nemcova T; Hoferova Z; Vasickova K; Smyckova L; Egle A; Pavlova S; Poppova L; Plevova K; Pospisilova S; Bryja V
    Blood; 2018 Mar; 131(11):1206-1218. PubMed ID: 29317454
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Newly Developed CK1-Specific Inhibitors Show Specifically Stronger Effects on CK1 Mutants and Colon Cancer Cell Lines.
    Liu C; Witt L; Ianes C; Bischof J; Bammert MT; Baier J; Kirschner S; Henne-Bruns D; Xu P; Kornmann M; Peifer C; Knippschild U
    Int J Mol Sci; 2019 Dec; 20(24):. PubMed ID: 31817920
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IC261, a specific inhibitor of CK1δ/ε, promotes aerobic glycolysis through p53-dependent mechanisms in colon cancer.
    Liu M; Hu Y; Lu S; Lu M; Li J; Chang H; Jia H; Zhou M; Ren F; Zhong J
    Int J Biol Sci; 2020; 16(5):882-892. PubMed ID: 32071557
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 3,4-Diaryl-isoxazoles and -imidazoles as potent dual inhibitors of p38alpha mitogen activated protein kinase and casein kinase 1delta.
    Peifer C; Abadleh M; Bischof J; Hauser D; Schattel V; Hirner H; Knippschild U; Laufer S
    J Med Chem; 2009 Dec; 52(23):7618-30. PubMed ID: 19591487
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of gamma-secretase by the CK1 inhibitor IC261 does not depend on CK1delta.
    Höttecke N; Liebeck M; Baumann K; Schubenel R; Winkler E; Steiner H; Schmidt B
    Bioorg Med Chem Lett; 2010 May; 20(9):2958-63. PubMed ID: 20350806
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural basis for the potent and selective inhibition of casein kinase 1 epsilon.
    Long AM; Zhao H; Huang X
    J Med Chem; 2012 Nov; 55(22):10307-11. PubMed ID: 23106386
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of highly selective casein kinase 1δ/1ε (CK1δ/ε) inhibitors with potent antiproliferative properties.
    Bibian M; Rahaim RJ; Choi JY; Noguchi Y; Schürer S; Chen W; Nakanishi S; Licht K; Rosenberg LH; Li L; Feng Y; Cameron MD; Duckett DR; Cleveland JL; Roush WR
    Bioorg Med Chem Lett; 2013 Aug; 23(15):4374-80. PubMed ID: 23787102
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and biological evaluation of 2,5-diaminobenzamide derivatives as anti-proliferating agents.
    Lee SH; Park JW; Hong JE; Park JW; Lee J
    Arch Pharm Res; 2009 Jun; 32(6):803-12. PubMed ID: 19557356
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CK1δ activity is modulated by CDK2/E- and CDK5/p35-mediated phosphorylation.
    Ianes C; Xu P; Werz N; Meng Z; Henne-Bruns D; Bischof J; Knippschild U
    Amino Acids; 2016 Feb; 48(2):579-92. PubMed ID: 26464264
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and identification of unprecedented selective inhibitors of CK1ε.
    Silveira-Dorta G; Sousa IJ; Fernandes MX; Martín VS; Padrón JM
    Eur J Med Chem; 2015; 96():308-17. PubMed ID: 25899335
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.